|
Scientific articles
The science behind CXL and PACK-CXL
|
Power up! More UV needed to treat IK
PACK-CXL for infectious keratitis is not like treating keratoconus with CXL.
Review on PACK-Crosslinking
The most recent and complete overview about this exciting new technology to treat corneal infections with UV light and Vitamin B2.
PACK-CXL in fungal keratitis
Article describing the successful use of PACK-CXL as primary therapy in contact lens-related fungal keratitis.
Prospective study on PACK-CXL
The so far largest study on PACK-CXL for the treatment of advanced corneal ulcers. Led by ELZA member Farhad Hafezi.
PACK-CXL can be accelerated
ELZA research shows that PACK-CXL can be accelerated from 30 minutes to 150 seconds only, while maintaining efficacy.
Defining PACK-CXL for keratitis
ELZA members define the new term for cross-linking for corneal infection.
Impact of Fluorescein on PACK-CXL
Study showing that the eye surgeon must avoid fluorescein staining of a corneal ulcer immediately prior to PACK-CXL.
CXL in Bullous Keratopathy, Veterinary Use
Scientific study on the value of PACK-CXL for the treatment of bullous keratopathy for veterinary use.
CXL for Melting Keratitis, Veterinary Use
Case series on the use of PACK-CXL for melting keratitis in the veterinary field.
CXL in Infectious Corneal Melting, Veterinary Use
Scientific study on the value of PACK-CXL for the treatment of infectious and non-infectious corneal melting for veterinary use.
PACK-CXL to treat Acanthamoeba keratitis
ELZA members on the effectiveness of Cross-Linking to treat Acanthamoeba keratitis.
Cross-linking for Infectious Keratitis
The very first report on cross-linking for corneal infection.
